|
|
|
|
|
文献清单:2025年高浏览Review鉴读|MDPI Antibodies |
|
|
期刊名:Antibodies
期刊主页:https://www.mdpi.com/journal/antibodies
本期编辑荐读为您精选2025年发表于 Antibodies 期刊的十篇高浏览review。希望能为相关领域学者提供新的思路和参考,欢迎阅读。
1. Immune Cell Engagers: Advancing Precision Immunotherapy for Cancer Treatment
免疫细胞接合器:推进癌症治疗的精确免疫疗法
http://www.mdpi.com/2073-4468/14/1/16
In, H.; Park, M.; Lee, H.; Han, K.H. Immune Cell Engagers: Advancing Precision Immunotherapy for Cancer Treatment. Antibodies 2025, 14, 16.
2. Fragment-Based Immune Cell Engager Antibodies in Treatment of Cancer, Infectious and Autoimmune Diseases: Lessons and Insights from Clinical and Translational Studies
基于片段的免疫细胞接合抗体治疗癌症、传染病和自身免疫性疾病:来自临床和转化研究的经验和见解
http://www.mdpi.com/2073-4468/14/3/52
Yang, G.; Massumi, M. Fragment-Based Immune Cell Engager Antibodies in Treatment of Cancer, Infectious and Autoimmune Diseases: Lessons and Insights from Clinical and Translational Studies. Antibodies 2025, 14, 52.
3. FcRn Blockade as a Targeted Therapeutic Strategy in Antibody-Mediated Autoimmune Diseases: A Focus on Warm Autoimmune Hemolytic Anemia
FcRn阻断作为抗体介导的自身免疫性疾病的靶向治疗策略:以温型自身免疫性溶血性贫血为中心
http://www.mdpi.com/2073-4468/14/3/65
Sandhu, M.; Murakhovskaya, I. FcRn Blockade as a Targeted Therapeutic Strategy in Antibody-Mediated Autoimmune Diseases: A Focus on Warm Autoimmune Hemolytic Anemia. Antibodies 2025, 14, 65.
4. Challenges and Insights in Absolute Quantification of Recombinant Therapeutic Antibodies by Mass Spectrometry: An Introductory Review
质谱绝对定量重组治疗性抗体的挑战和见解:介绍性综述
http://www.mdpi.com/2073-4468/14/1/3
Döring, S.; Weller, M.G.; Reinders, Y.; Konthur, Z.; Jaeger, C. Challenges and Insights in Absolute Quantification of Recombinant Therapeutic Antibodies by Mass Spectrometry: An Introductory Review. Antibodies 2025, 14, 3.
5. Future Landscape of Anti-Claudin 18.2 Antibodies in Gastric Adenocarcinoma
抗Claudin 18.2抗体在胃腺癌中的应用前景
http://www.mdpi.com/2073-4468/14/1/26
Covert, W.M.; Rogers, J.E. Future Landscape of Anti-Claudin 18.2 Antibodies in Gastric Adenocarcinoma. Antibodies 2025, 14, 26.
6. How Broadly Neutralising Antibodies Are Redefining Immunity to Influenza
广谱中和抗体如何重新定义对流感的免疫认知
http://www.mdpi.com/2073-4468/14/1/4
Steventon, R.; Stolle, L.; Thompson, C.P. How Broadly Neutralising Antibodies Are Redefining Immunity to Influenza. Antibodies 2025, 14, 4.
7. Anti-ADAMTS13 Autoantibodies in Immune-Mediated Thrombotic Thrombocytopenic Purpura
抗ADAMTS13自身抗体在免疫介导的血栓性血小板减少性紫癜中的作用
http://www.mdpi.com/2073-4468/14/1/24
Snyder, M.R.; Maitta, R.W. Anti-ADAMTS13 Autoantibodies in Immune-Mediated Thrombotic Thrombocytopenic Purpura. Antibodies 2025, 14, 24.
8. Infertility and Auto-Antibodies: A Review
不孕症与自身抗体的研究进展
http://www.mdpi.com/2073-4468/14/3/76
Šemeklien?, B.; Gradauskien?, B. Infertility and Auto-Antibodies: A Review. Antibodies 2025, 14, 76.
9. Regulatory T Cell in Kidney Transplant: The Future of Cell Therapy?
肾移植中的调节性T细胞:细胞治疗的未来?
http://www.mdpi.com/2073-4468/14/2/49
Matarneh, A.; Patel, M.; Parikh, K.; Karasinski, A.; Kaur, G.; Shah, V.; Ghahramani, N.; Trivedi, N. Regulatory T Cell in Kidney Transplant: The Future of Cell Therapy? Antibodies 2025, 14, 49.
10. Avian Antibodies as Potential Therapeutic Tools
禽源抗体作为潜在治疗工具
http://www.mdpi.com/2073-4468/14/1/18
Eriksson, M.; Larsson, A. Avian Antibodies as Potential Therapeutic Tools. Antibodies 2025, 14, 18.
Antibodies期刊介绍

主编:Arne Skerra, Technical University of Munich, Germany
期刊主题涵盖抗体和体液免疫反应、抗体的发现、产生和选择、抗体结构和功能、抗体工程、结合物和融合蛋白、生物医学研究和治疗中的抗体。
2025 Impact Factor: 3.3
2025 CiteScore: 4.9
Time to First Decision: 19.5 Days
Acceptance to Publication: 5.7 Days
特别声明:本文转载仅仅是出于传播信息的需要,并不意味着代表本网站观点或证实其内容的真实性;如其他媒体、网站或个人从本网站转载使用,须保留本网站注明的“来源”,并自负版权等法律责任;作者如果不希望被转载或者联系转载稿费等事宜,请与我们接洽。